Two Sigma Investments, LP Relmada Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
A detailed history of Two Sigma Investments, LP transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 170,544 shares of RLMD stock, worth $127,908. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170,544
Previous 127,579
33.68%
Holding current value
$127,908
Previous $66,000
30.3%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RLMD
# of Institutions
49Shares Held
6.3MCall Options Held
0Put Options Held
0-
Acadian Asset Management LLC Boston, MA1.23MShares$920,9460.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$906,0560.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$429,9850.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$371,3590.03% of portfolio
-
Geode Capital Management, LLC Boston, MA302KShares$226,4120.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $21.5M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...